Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Roberto Latini"'
Autor:
Nicolas Girerd, Daniel Levy, Kevin Duarte, Joao Pedro Ferreira, Christie Ballantyne, Timothy Collier, Anne Pizard, Jens Björkman, Javed Butler, Andrew Clark, John G. Cleland, Christian Delles, Javier Diez, Arantxa González, Mark Hazebroek, Jennifer Ho, Anne-Cécile Huby, Shih-Jen Hwang, Roberto Latini, Beatrice Mariottoni, Alexandre Mebazaa, Pierpaolo Pellicori, Naveed Sattar, Peter Sever, Jan A. Staessen, Job Verdonschot, Stephane Heymans, Patrick Rossignol, Faiez Zannad
Publikováno v:
Circulation: Heart Failure. 16
Background: We sought to identify protein biomarkers of new-onset heart failure (HF) in 3 independent cohorts (HOMAGE cohort [Heart Omics and Ageing], ARIC study [Atherosclerosis Risk in Communities], and FHS [Framingham Heart Study]) and assess if a
Autor:
Kui Toh Gerard Leong, Fazlur Jaufeerally, Carolyn S.P. Lam, Kai M. Eggers, Roberto Latini, Alberto Aimo, Robert N. Doughty, Hean Yee Ong, Josep Lupón, Inder S. Anand, Giuseppe Vergaro, Kurt Huber, Ida Gustafsson, Richard W. Troughton, Yasuchika Takeishi, Michele Emdin, Tze P. Ng, Lidia Staszewsky, Claudio Passino, Antoni Bayes-Genis, Akiomi Yoshihisa, James L. Januzzi, Poh Shuan Daniel Yeo, Rudolf A. de Boer, A. Mark Richards, Hans-Peter Brunner-La Rocca, Thor Ueland, Greg D. Gamble
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.), 23(1), 28-36
Journal of Cardiovascular Medicine, 23(1), 28-36. LIPPINCOTT WILLIAMS & WILKINS
Journal of Cardiovascular Medicine, 23(1), 28-36. LIPPINCOTT WILLIAMS & WILKINS
AIMS: Chronic obstructive pulmonary disease (COPD) is a frequent comorbidity in patients with heart failure (HF). We assessed the influence of COPD on circulating levels and prognostic value of three HF biomarkers: N-terminal pro-B-type natriuretic p
Autor:
Giuseppe Vergaro, Yasuchika Takeishi, Ida Gustafsson, Inder S. Anand, Kai M. Eggers, Michael Egstrup, Aldo Clerico, Andrea Ripoli, Jay N. Cohn, Jennifer Meessen, Nick Marcks, Akiomi Yoshihisa, Claudio Passino, Hanna K. Gaggin, Alberto Aimo, Thor Ueland, Michele Emdin, Josep Lupón, Roberto Latini, James L. Januzzi, Antoni Bayes-Genis, Sandra Sanders-van Wijk, Ioannis Tentzeris, Rudolf A. de Boer, Jørgen Gravning, Kurt Huber, Hans-Peter Brunner-La Rocca
Publikováno v:
Clinical research in cardiology, 110(8), 1280-1291. Springer
Clinical Research in Cardiology, 110(8), 1280-1291. SPRINGER HEIDELBERG
Clinical Research in Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Clinical Research in Cardiology, 110(8), 1280-1291. SPRINGER HEIDELBERG
Clinical Research in Cardiology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comor
Autor:
Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet
Publikováno v:
JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
OBJECTIVES This study sought to further understand the mechanisms underlying effect of spironolactone and assessed its impact on multiple plasma protein biomarkers and their respective underlying biologic pathways.BACKGROUND In addition to their bene
Autor:
Kui Tong Gerard Leong, Robert N. Doughty, Fazlur Jaufeerally, Giuseppe Vergaro, Lars Gullestad, Jay N. Cohn, Antoni Bayes-Genis, Hans-Peter Brunner-La Rocca, Michele Emdin, Lieng H. Ling, Ida Gustafsson, Michael Egstrup, Kai M. Eggers, Yasuchika Takeishi, Hanna K. Gaggin, Hean Yee Ong, Richard W. Troughton, A. Mark Richards, Thor Ueland, Inder S. Anand, James L. Januzzi, Roberto Latini, Rudolf A. de Boer, Pål Aukrust, Claudio Passino, Carolyn S.P. Lam, Alberto Aimo, Josep Lupón, Tze P. Ng, Greg D. Gamble, Kurt Huber, Poh Shuah Daniel Yeo
Publikováno v:
European Journal of Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of heart failure, 22(11), 2078-2088. Wiley
European Journal of Heart Failure, 22(11), 2078-2088. Wiley
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of heart failure, 22(11), 2078-2088. Wiley
European Journal of Heart Failure, 22(11), 2078-2088. Wiley
This is the peer reviewed version of the following article: Aimo, A., Januzzi, J.L., Vergaro, G., Richards, A.M., Lam, C.S.P., Latini, R. ... Emdin, M. (2020). Circulating levels and prognostic value of soluble ST2 in heart failure are less influence
Autor:
Joseph J Cuthbert, Pierpaolo Pellicori, Johannes Petutschnigg, Franco Cosmi, Blerim Mujaj, João Pedro Ferreira, Fozia Z Ahmed, Nicolas Girerd, Faiez Zannad, Roberto Latini, Timothy Collier, Patrick Rossignol, Beatrice Mariottoni, Jan A. Staessen, John G.F. Cleland, Stephane Heymans, Andrew L. Clark, Job A J Verdonschot, Arantxa González, Hans-Peter Brunner-La Rocca
Publikováno v:
European journal of heart failure, 22(9), 1711-1723. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
European Journal of Heart Failure, 2020, 22 (7), pp.1711-1723. ⟨10.1002/ejhf.1716⟩
International audience; AIMS:Asymptomatic patients with coronary artery disease (CAD), hypertension and/or type 2 diabetes mellitus (T2DM) are at greater risk of developing heart failure (HF). Fibrosis, leading to myocardial and vascular dysfunction,
Autor:
Giuseppe Vergaro, Francesco Gentile, Alberto Aimo, James L. Januzzi, A. Mark Richards, Carolyn S.P. Lam, Rudolf A. de Boer, Laura M.G. Meems, Roberto Latini, Lidia Staszewsky, Inder S. Anand, Jay N. Cohn, Thor Ueland, Lars Gullestad, Pål Aukrust, Hans‐Peter Brunner‐La Rocca, Antoni Bayes‐Genis, Josep Lupón, Akiomi Yoshihisa, Yasuchika Takeishi, Michael Egstrup, Ida Gustafsson, Hanna K. Gaggin, Kai M. Eggers, Kurt Huber, Greg D. Gamble, Lieng H. Ling, Kui Toh Gerard Leong, Poh Shuah Daniel Yeo, Hean Yee Ong, Fazlur Jaufeerally, Tze P. Ng, Richard Troughton, Robert N. Doughty, Gerry Devlin, Mayanna Lund, Alberto Giannoni, Claudio Passino, Michele Emdin
Publikováno v:
ESC Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Esc heart failure, 9(4), 2084-2095. John Wiley & Sons Inc.
ESC Heart Failure, 9(4), 2084-2095. WILEY PERIODICALS, INC
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Esc heart failure, 9(4), 2084-2095. John Wiley & Sons Inc.
ESC Heart Failure, 9(4), 2084-2095. WILEY PERIODICALS, INC
AIMS: To define plasma concentrations, determinants, and optimal prognostic cut-offs of soluble suppression of tumorigenesis-2 (sST2), high-sensitivity cardiac troponin T (hs-cTnT), and N-terminal pro-B-type natriuretic peptide (NT-proBNP) in women a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e292f416d790f2336a4e2af2d58a0bb3
http://hdl.handle.net/11382/548311
http://hdl.handle.net/11382/548311
Autor:
Aldo P. Maggioni, Donata Lucci, Maria Grazia Franzosi, Roberto Latini, Gianni Tognoni, Jennifer Meessen, Deborah Novelli, Marcello Disertori, Lidia Staszewsky, Serge Masson, Ursula-Henrike Wienhues-Thelen
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cardiovascular Disorders
BMC Cardiovascular Disorders
Background Novel circulating biomarkers may help in understanding the underlying mechanisms of atrial fibrillation (AF), a challenge for AF management and prevention of cardiovascular (CV) events. Whether glycosylation affects the prognostic value of
Autor:
Roberta Manuguerra, Angeliki Asimaki, Laura Cavallotti, Roberto Marchioli, Aneta Aleksova, Peter Libby, Dariush Mozaffarian, Jennifer Meessen, Caterina Simon, Jeffrey E. Saffitz, Luigi Tavazzi, Luca Dozza, Serge Masson, Rodolfo Monaco, Renato Gregorini, Deborah Novelli, Roberto Latini, Domenico Corradi, Emanuela Oldoni
Publikováno v:
Circ Arrhythm Electrophysiol
Background: Postoperative atrial fibrillation (POAF) occurs in 30% to 50% of patients undergoing cardiac surgery and is associated with increased morbidity and mortality. Prospective identification of structural/molecular changes in atrial myocardium
Autor:
Barbara Bottazzi, Giuseppe Curigliano, Maria Teresa Sandri, Roberto Leone, Jennifer Meessen, Pietro Cortesi, Daniele Nassiacos, Enrico Nicolis, Alessandra Bianchi, Deborah Novelli, Alberto Farolfi, Icos‐One Study Investigators, Cecilia Garlanda, Giovanna Balconi, Alessandro Colombo, Marco Bregni, Enrico Barbieri, Roberto Latini, Daniela Cardinale, Carlo M. Cipolla, Maurizio Civelli, Paolo Pastori, Stefania Gori, Lidia Staszewsky, Alberto Mantovani, Serge Masson, Carlo Milandri, Fabio Ciceri, Francesco Ghisoni, Gianluigi Condorelli, Michela Salvatici, Claudio Verusio, Alessandra Malossi, Maria Grazia Franzosi, Cristina Falci, GianFranco Cucchi, Maurizio Mangiavacchi, Anna Monopoli, Elisabetta Menatti
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 7, Iss 4, Pp 1452-1466 (2020)
ESC Heart Failure, Vol 7, Iss 4, Pp 1452-1466 (2020)
Aims: A multicentre trial, ICOS-ONE, showed increases above the upper limit of normality of cardiac troponin (cTn) in 27% of patients within 12months after the end of cancer chemotherapy (CT) with anthracyclines, whether cardiac protection with enala
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c511c2721aae8b91ddc1e26717b85b1